Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Abstract Background Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth with short-term and long-term adverse consequences. Although the glucocorticoid dexamethasone has been proven to be beneficial for the prevention of BPD, there are concerns about an increased risk o...
Main Authors: | Wes Onland, Maruschka P. Merkus, Debbie H. Nuytemans, Marijke C. Jansen-van der Weide, Rebecca Holman, Anton H. van Kaam, on behalf of the SToP-BPD study group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-018-2505-y |
Similar Items
-
Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial
by: Yuan He, et al.
Published: (2020-09-01) -
Nutritional status and bronchopulmonary dysplasia (BPD)
by: Chehade, Joyce P.
Published: (1994) -
Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
by: Pragnya Das, et al.
Published: (2021-08-01) -
Where are we now with the role of steroids in the management of bronchopulmonary dysplasia (BPD) in extremely premature babies?
by: MATTHEW HURLEY, et al.
Published: (2016-08-01) -
Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
by: Christopher A. M. Bannon, et al.
Published: (2021-03-01)